A Senate committee opened an investigation into Novo Nordisk’s list prices for Ozempic and Wegovy, Novo Nordisk’s diabetes and weight loss drugs.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Senate to probe Ozempic, Wegovy's cost
